SMSPHARMA logo

SMS Pharmaceuticals Limited Stock Price

NSEI:SMSPHARMA Community·₹31.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

SMSPHARMA Share Price Performance

₹0
-223.65 (-100.00%)
₹0
-223.65 (-100.00%)
Price ₹0

SMSPHARMA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
1 Reward

SMS Pharmaceuticals Limited Key Details

₹8.6b

Revenue

₹5.8b

Cost of Revenue

₹2.8b

Gross Profit

₹2.0b

Other Expenses

₹843.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
9.01
32.97%
9.81%
44.5%
View Full Analysis

About SMSPHARMA

Founded
1987
Employees
1470
CEO
Ramesh Potluri
WebsiteView website
smspharma.com

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.

Recent SMSPHARMA News & Updates

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals

Nov 16
SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals

Recent updates

No updates